Monitoring brain injury biomarkers and glucose variation in patients who have suffered an acute cranial injury during the entire first week of hospitalization can provide a more accurate picture of the pathological process. This is according to a paper published in The Lancet Neurology by researchers at Karolinska Institutet in Sweden. It is hoped that their findings can eventually lead to more personalized treatment.
Leave A Comment